Tamir Ailon1, Radmehr Torabi2, Charles G Fisher1, Laurence D Rhines3, Michelle J Clarke4, Chetan Bettegowda5, Stefano Boriani6, Yoshiya J Yamada7, Norio Kawahara8, Peter P Varga9, John H Shin10, Arjun Saghal11, Ziya L Gokaslan2. 1. Division of Spine, Department of Orthopaedics, University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada. 2. Department of Neurosurgery, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI. 3. Department of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. 4. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN. 5. Department of Neurosurgery, The John Hopkins University School of Medicine, Baltimore, MD. 6. Department of Degenerative and Oncological Spine Surgery, Rizzoli Institute Bologna, Bologna, Italy. 7. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. 8. Department of Orthopaedic Surgery, Kanazawa Medical University, Uchinada, Japan. 9. National Center for Spinal Disorders, Budapest, Hungary. 10. Department of Neurosurgery, Massachusetts General Hospital, Harvard University, Boston, MA. 11. Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
Abstract
STUDY DESIGN: Systematic review. OBJECTIVE: To determine evidence-based guidelines for the management of locally recurrent spinal chordoma. SUMMARY OF BACKGROUND DATA: Chordoma of the spine is a low-grade malignant tumor with a strong propensity for local recurrence. Salvage therapy is challenging due to its relentless nature and refractoriness to adjuvant therapies. There are currently no guidelines regarding the best management of recurrent chordoma. METHODS: We combined the results of a systematic review with expert opinion to address the following research questions: (1) For locally recurrent chordoma of the spine without systemic disease, if surgery is planned, should en bloc resection be attempted if technically feasible with acceptable morbidity? (2) For locally recurrent chordoma without systemic disease, in which wide en bloc excision is not possible, what is the treatment of choice? (2) Should adjuvant or neoadjuvant radiation therapy be used in the treatment of locally recurrent chordoma? RESULTS: A total of nine surgical and seven radiation therapy articles met study criteria. Evidence quality was low or very low. Recurrent disease is associated with predominantly poor outcome, regardless of treatment modality. As for primary chordoma, resection with wide margins appears to confer an advantage with respect to local control, although this effect is attenuated in the setting of relapse. Postoperative radiation therapy likely reduces the rate of further relapse. CONCLUSION: (1) For locally recurrent chordoma of the spine without systemic disease, when surgery is planned, wide en bloc resection should be performed if technically feasible with acceptable morbidity. Strong recommendation, Low Quality of Evidence. (2) For locally recurrent chordoma without systemic disease, in which wide en bloc excision is not possible, partial resection is the treatment of choice. Weak recommendation, Very Low Quality of Evidence. (3) For the treatment of locally recurrent chordoma, high-dose conformal radiation therapy should be administered postoperatively to reduce the risk of further recurrence, and may be considered as a primary therapy. Strong recommendation, Very Low Quality of Evidence. LEVEL OF EVIDENCE: 2.
STUDY DESIGN: Systematic review. OBJECTIVE: To determine evidence-based guidelines for the management of locally recurrent spinal chordoma. SUMMARY OF BACKGROUND DATA: Chordoma of the spine is a low-grade malignant tumor with a strong propensity for local recurrence. Salvage therapy is challenging due to its relentless nature and refractoriness to adjuvant therapies. There are currently no guidelines regarding the best management of recurrent chordoma. METHODS: We combined the results of a systematic review with expert opinion to address the following research questions: (1) For locally recurrent chordoma of the spine without systemic disease, if surgery is planned, should en bloc resection be attempted if technically feasible with acceptable morbidity? (2) For locally recurrent chordoma without systemic disease, in which wide en bloc excision is not possible, what is the treatment of choice? (2) Should adjuvant or neoadjuvant radiation therapy be used in the treatment of locally recurrent chordoma? RESULTS: A total of nine surgical and seven radiation therapy articles met study criteria. Evidence quality was low or very low. Recurrent disease is associated with predominantly poor outcome, regardless of treatment modality. As for primary chordoma, resection with wide margins appears to confer an advantage with respect to local control, although this effect is attenuated in the setting of relapse. Postoperative radiation therapy likely reduces the rate of further relapse. CONCLUSION: (1) For locally recurrent chordoma of the spine without systemic disease, when surgery is planned, wide en bloc resection should be performed if technically feasible with acceptable morbidity. Strong recommendation, Low Quality of Evidence. (2) For locally recurrent chordoma without systemic disease, in which wide en bloc excision is not possible, partial resection is the treatment of choice. Weak recommendation, Very Low Quality of Evidence. (3) For the treatment of locally recurrent chordoma, high-dose conformal radiation therapy should be administered postoperatively to reduce the risk of further recurrence, and may be considered as a primary therapy. Strong recommendation, Very Low Quality of Evidence. LEVEL OF EVIDENCE: 2.
Authors: Thomas F DeLaney; Norbert J Liebsch; Frank X Pedlow; Judith Adams; Elizabeth A Weyman; Beow Y Yeap; Nicolas Depauw; G Petur Nielsen; David C Harmon; Sam S Yoon; Yen-Lin Chen; Joseph H Schwab; Francis J Hornicek Journal: J Surg Oncol Date: 2014-04-19 Impact factor: 3.454
Authors: Ziya L Gokaslan; Patricia L Zadnik; Daniel M Sciubba; Niccole Germscheid; C Rory Goodwin; Jean-Paul Wolinsky; Chetan Bettegowda; Mari L Groves; Alessandro Luzzati; Laurence D Rhines; Charles G Fisher; Peter Pal Varga; Mark B Dekutoski; Michelle J Clarke; Michael G Fehlings; Nasir A Quraishi; Dean Chou; Jeremy J Reynolds; Richard P Williams; Norio Kawahara; Stefano Boriani Journal: J Neurosurg Spine Date: 2015-12-18
Authors: Péter Pál Varga; Zsolt Szövérfi; Charles G Fisher; Stefano Boriani; Ziya L Gokaslan; Mark B Dekutoski; Dean Chou; Nasir A Quraishi; Jeremy J Reynolds; Alessandro Luzzati; Richard Williams; Michael G Fehlings; Niccole M Germscheid; Aron Lazary; Laurence D Rhines Journal: Eur Spine J Date: 2014-12-23 Impact factor: 3.134
Authors: Matthias Uhl; Thomas Welzel; Alexandra Jensen; Malte Ellerbrock; Thomas Haberer; Oliver Jäkel; Klaus Herfarth; Jürgen Debus Journal: Strahlenther Onkol Date: 2015-03-04 Impact factor: 3.621
Authors: Silvia Stacchiotti; Paolo Giovanni Casali; Salvatore Lo Vullo; Luigi Mariani; Elena Palassini; Mario Mercuri; Marco Alberghini; Silvana Pilotti; Licciana Zanella; Alessandro Gronchi; Piero Picci Journal: Ann Surg Oncol Date: 2009-10-22 Impact factor: 5.344
Authors: Ronny L Rotondo; Wendy Folkert; Norbert J Liebsch; Yen-Lin E Chen; Frank X Pedlow; Joseph H Schwab; Andrew E Rosenberg; G Petur Nielsen; Jackie Szymonifka; Al E Ferreira; Francis J Hornicek; Thomas F DeLaney Journal: J Neurosurg Spine Date: 2015-09-04
Authors: Mark D Murphey; Matthew J Minn; Alejandro Luiña Contreras; Kelly K Koeller; Robert Y Shih; Carrie Y Inwards; Takehiko Yamaguchi Journal: Skeletal Radiol Date: 2022-09-05 Impact factor: 2.128
Authors: Jeffrey A Zuccato; Christopher D Witiw; Julia Keith; Erin Dyer; Arjun Saghal; Leodante da Costa Journal: Spinal Cord Ser Cases Date: 2018-03-13
Authors: Daniel Kerekes; C Rory Goodwin; A Karim Ahmed; Jorrit-Jan Verlaan; Chetan Bettegowda; Nancy Abu-Bonsrah; Daniel M Sciubba Journal: Global Spine J Date: 2018-05-30
Authors: Elie Massaad; Nida Fatima; Muhamed Hadzipasic; Christopher Alvarez-Breckenridge; Ganesh M Shankar; John H Shin Journal: Neurospine Date: 2019-12-31